Biomedix vascular solution
Saint Paul
About Biomedix vascular solution
Founded in 1997, BioMedix is a leader in Health Information Technology (HIT) software, products and services that connect primary care providers, vascular labs, vascular specialists and healthcare systems in a continuum of collaborative care. We provide the only integrated suite of hardware, software and online services designed to cost-effectively detect vascular disease. Our award-winning suite of medical devices, advanced practice management and Electronic Health Record (EHR) software and web-based solutions give providers a more complete view of patient care. BioMedix products are designed to share information and work together in a continuum of care. PADnet® and VEINnet™ devices for in-office vascular testing for the early detection of arterial and venous disease. TRAKnet® PM - DPM Edition integrated electronic health records (EHR) and Advanced Practice Management Solutions. TRAKnet Lab software improves lab efficiency and supports IAC (Vascular Testing) accreditation. TRAKnet Outcomes tracking software improves financial and therapeutic outcomes. PADnet Disease Management System 2.0 for developing best practices for vascular planning and growth. Technological innovation, a deep understanding of vascular care and concern for the needs of patients have made BioMedix the leading provider of integrated solutions for non-invasive vascular diagnostics and vascular lab management. Medical professionals can analyze clinical data and patient demographics to get a complete picture of vascular health. The result is faster and better diagnosis of vascular disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $682.2K
- Last round: Debt Financing (Nov 2012)
- Website: biomedix.com
- Phone: 651-762-4010
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/biomedix-vascular-solution-2419646 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.